Bausch Health Cos Net Profit Margin 2010-2024 | BHC

Bausch Health Cos net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Bausch Health Cos Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-09-30 $9.47B $-0.18B -1.88%
2024-06-30 $9.20B $-0.47B -5.12%
2024-03-31 $8.97B $-0.46B -5.07%
2023-12-31 $8.76B $-0.59B -6.76%
2023-09-30 $8.54B $-0.96B -11.27%
2023-06-30 $8.35B $-0.19B -2.23%
2023-03-31 $8.15B $-0.36B -4.38%
2022-12-31 $8.12B $-0.23B -2.77%
2022-09-30 $8.13B $0.25B 3.13%
2022-06-30 $8.19B $0.04B 0.52%
2022-03-31 $8.33B $-0.41B -4.89%
2021-12-31 $8.43B $-0.95B -11.24%
2021-09-30 $8.45B $-1.17B -13.84%
2021-06-30 $8.48B $-1.29B -15.18%
2021-03-31 $8.04B $-1.02B -12.66%
2020-12-31 $8.03B $-0.56B -6.98%
2020-09-30 $8.04B $-1.92B -23.92%
2020-06-30 $8.11B $-2.04B -25.19%
2020-03-31 $8.60B $-1.89B -21.96%
2019-12-31 $8.60B $-1.79B -20.79%
2019-09-30 $8.50B $-0.62B -7.25%
2019-06-30 $8.43B $-0.92B -10.88%
2019-03-31 $8.40B $-1.62B -19.27%
2018-12-31 $8.38B $-4.15B -49.50%
2018-09-30 $8.42B $-3.29B -39.08%
2018-06-30 $8.51B $-1.64B -19.28%
2018-03-31 $8.61B $-0.81B -9.35%
2017-12-31 $8.72B $2.40B 27.56%
2017-09-30 $8.96B $1.38B 15.35%
2017-06-30 $9.22B $-1.14B -12.39%
2017-03-31 $9.41B $-1.41B -14.95%
2016-12-31 $9.67B $-2.41B -24.90%
2016-09-30 $10.03B $-2.28B -22.73%
2016-06-30 $10.34B $-1.01B -9.79%
2016-03-31 $10.65B $-0.76B -7.16%
2015-12-31 $10.45B $-0.29B -2.79%
2015-09-30 $9.91B $0.60B 6.02%
2015-06-30 $9.18B $0.82B 8.95%
2015-03-31 $8.49B $1.00B 11.79%
2014-12-31 $8.21B $0.88B 10.72%
2014-09-30 $8.05B $0.50B 6.24%
2014-06-30 $7.53B $-0.75B -9.90%
2014-03-31 $6.59B $-0.86B -13.07%
2013-12-31 $5.77B $-0.87B -15.01%
2013-09-30 $4.63B $-1.08B -23.32%
2013-06-30 $3.97B $-0.10B -2.47%
2013-03-31 $3.69B $-0.13B -3.55%
2012-12-31 $3.48B $-0.12B -3.33%
2012-09-30 $3.21B $0.03B 0.90%
2012-06-30 $2.93B $0.06B 2.12%
2012-03-31 $2.72B $0.14B 5.15%
2011-12-31 $2.43B $0.16B 6.55%
2011-09-30 $2.29B $0.07B 3.14%
2011-06-30 $1.90B $-0.18B -9.33%
2011-03-31 $1.53B $-0.20B -13.03%
2010-12-31 $1.18B $-0.21B -17.60%
2010-09-30 $0.91B $-0.10B -11.45%
2010-06-30 $0.91B $0.14B 15.77%
2010-03-31 $0.87B $0.13B 15.44%
2009-12-31 $0.82B $0.18B 21.44%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.597B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00